[Pharmaceutical interventions in the new medicine service].

IF 0.5 Q4 HEALTH POLICY & SERVICES

Farmaceuticos Comunitarios Pub Date : 2025-06-18 eCollection Date: 2025-07-15 DOI:10.33620/FC.2173-9218.(2025).19

S Borja Ripoll, F Mocholí Belenguer, V Traver Salcedo

{"title":"[Pharmaceutical interventions in the new medicine service].","authors":"S Borja Ripoll, F Mocholí Belenguer, V Traver Salcedo","doi":"10.33620/FC.2173-9218.(2025).19","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>It is possible that traffic accidents caused by medication use are among the most underestimated compared with other types of accidents.This issue stems from human factors that affect driving even before it begins, increasing the likelihood of accidents. Therefore, it is a predictable and avoidable factor.In this context, it is essential to gain a deeper understanding of the medications that pose the greatest risks and how they influence driving.To do this, we will study the groups of drugs marketed in the European Union that can affect driving, analyzing the DRUID classification of medicines to determine which group of drugs can have the most influence on driving.To this end, the DRUID classification has been reviewed, the technical data sheets of medications marketed in Spain have been analyzed, focusing on the sections regarding \"Effects on driving\" and \"Adverse effects,\" and the frequency of these effects has been evaluated to identify the medications with the greatest impact.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 3","pages":"17-25"},"PeriodicalIF":0.5000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12282469/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmaceuticos Comunitarios","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33620/FC.2173-9218.(2025).19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/15 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Abstract: It is possible that traffic accidents caused by medication use are among the most underestimated compared with other types of accidents.This issue stems from human factors that affect driving even before it begins, increasing the likelihood of accidents. Therefore, it is a predictable and avoidable factor.In this context, it is essential to gain a deeper understanding of the medications that pose the greatest risks and how they influence driving.To do this, we will study the groups of drugs marketed in the European Union that can affect driving, analyzing the DRUID classification of medicines to determine which group of drugs can have the most influence on driving.To this end, the DRUID classification has been reviewed, the technical data sheets of medications marketed in Spain have been analyzed, focusing on the sections regarding "Effects on driving" and "Adverse effects," and the frequency of these effects has been evaluated to identify the medications with the greatest impact.

查看原文本刊更多论文

[新药服务中的药物干预]。

摘要：与其他类型的交通事故相比，由药物引起的交通事故可能是最被低估的。这个问题源于人为因素，甚至在驾驶开始之前就影响了驾驶，增加了发生事故的可能性。因此，这是一个可预测和可避免的因素。在这种情况下，有必要更深入地了解构成最大风险的药物以及它们如何影响驾驶。为此，我们将研究在欧盟销售的可能影响驾驶的药物组，分析德鲁伊药物分类，以确定哪组药物对驾驶的影响最大。为此，对DRUID分类进行了审查，对在西班牙销售的药物的技术数据表进行了分析，重点关注“对驾驶的影响”和“不良影响”部分，并对这些影响的频率进行了评估，以确定影响最大的药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊